GSK ends Alector tie

Alector and GSK End Partnership Following Dementia, Alzheimer's Drug Failures

GSK terminated its neuroscience collaboration with Alector after clinical failures of two antibody drugs for dementia and Alzheimer's. The move follows late-stage setbacks and led to significant workf